BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32203224)

  • 1. DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.
    Wu C; Ding H; Wang S; Li Y; Liu SB; Wang X; Zheng J; Xue T; Amin HM; Song YH; Zhou J
    Br J Cancer; 2020 May; 122(10):1477-1485. PubMed ID: 32203224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.
    Wang B; Zheng J; Chen Q; Wu C; Li Y; Yu XY; Liu B; Liang C; Liu SB; Ding H; Wang S; Xue T; Song D; Lei Z; Amin HM; Song YH; Zhou J
    Carcinogenesis; 2020 Jul; 41(6):841-849. PubMed ID: 31560739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase promotes epithelial-mesenchymal transition through the ERK signaling pathway in gastric cancer.
    Lin H; Weng J; Mei H; Zhuang M; Xiao X; Du F; Lin L; Wu J; Chen Z; Huang Y; Chen F; Wang X
    J Gastroenterol Hepatol; 2021 Feb; 36(2):455-466. PubMed ID: 32667711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
    Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
    Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
    Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
    Li W; Wang Z; Zha L; Kong D; Liao G; Li H
    Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
    Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
    Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy.
    Peiffer DS; Wyatt D; Zlobin A; Piracha A; Ng J; Dingwall AK; Albain KS; Osipo C
    Cancer Res; 2019 Oct; 79(19):4965-4977. PubMed ID: 31387918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA MEG‑3 suppresses gastric carcinoma cell growth, invasion and migration via EMT regulation.
    Jiao J; Zhang S
    Mol Med Rep; 2019 Sep; 20(3):2685-2693. PubMed ID: 31524253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.
    Pajuelo-Lozano N; Alcalá S; Sainz B; Perona R; Sanchez-Perez I
    Theranostics; 2020; 10(21):9601-9618. PubMed ID: 32863948
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
    Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
    Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
    Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
    Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Qiao C; Liu G; Zhou H; Liu Q
    J Cell Mol Med; 2018 Jun; 22(6):3215-3222. PubMed ID: 29566309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis.
    Yoon C; Till J; Cho SJ; Chang KK; Lin JX; Huang CM; Ryeom S; Yoon SS
    Mol Cancer Res; 2019 Sep; 17(9):1945-1957. PubMed ID: 31217166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.